SCHEMBL7799376

SCHEMBL7799376

COc1cc2nc(N)nc(-c3cccc(Br)c3Br)c2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.51
EGFR P00533 1/20 0.51
DHFR P00374 2/20 0.44
SLC2A1 P11166 1/20 0.42
WHR1 P49842 1/20 0.42
DCPS Q96C86 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
ATM Q13315 1/20 0.39
FBP1 P09467 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
ADORA1 P30542 1/20 0.39
ACHE P22303 1/20 0.39
PDPK1 O15530 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790971 0.90 ADORA2A (0.57) ADORA2AEGFRDHFRSLC2A1WHR1
SCHEMBL7799233 0.80 ADORA2A (0.62) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL7799239 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRWHR1DCPS
SCHEMBL7790975 0.80 ADORA2A (0.51) ADORA2AEGFRDHFRWHR1DCPS
SCHEMBL7791033 0.79 ADORA2A (0.61) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL7585771 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL7800422 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL7791023 0.79 ADORA2A (0.57) ADORA2AEGFRDHFRWHR1HSP90AA1
SCHEMBL28594419 0.79 EGFR (0.45) ADORA2AEGFRDHFRSLC2A1WHR1
SCHEMBL1942672 0.78 EGFR (0.61) ADORA2AEGFRDHFRSLC2A1WHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163228-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF Parker Hughes Institute (US) 2001-12-19 EP disclosed
WO-2000056720-A1 QUINAZOLINES AND THERAPEUTIC USE THEREOF PARKER HUGHES INSTITUTE (US) 2000-09-28 WO disclosed